ArcherDX
Founded in 2013, ArcherDX is a biotechnology company that is focused on NGS-based gene fusion detection assays. Archer NGS assays are purpose-built to identify gene fusions, copy number variations, single nucleotide variants and more. They are headquartered in Boulder, Colorado.
Last updated on
About ArcherDX
Founded
2013Estimated Revenue
$50M-$100MEmployees
251-1KFunding / Mkt. Cap
$150MCategory
Industry
BiotechnologyLocation
City
BoulderState
ColoradoCountry
United StatesArcherDX
Find your buyer within ArcherDX